State Of Wisconsin Investment Board Aeglea Bio Therapeutics, Inc. Transaction History

State Of Wisconsin Investment Board

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 12, 2021	SELL	$6.32 - $8.38 $381,096 - $505,314	-60,300 Closed	0 $0
Q4 2020 Feb 03, 2021	SELL	$7.02 - $9.83 $52,650 - $73,725	-7,500 Reduced 11.06%	60,300 $475,000
Q3 2020 Nov 16, 2020	BUY	$6.51 - $9.33 $441,378 - $632,574	67,800 New	67,800 $481,000
Q1 2020 May 06, 2020	SELL	$3.51 - $8.48 $139,347 - $336,656	-39,700 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$7.23 - $8.55 $145,518 - $172,085	20,127 Added 102.83%	39,700 $303,000
Q3 2019 Nov 12, 2019	SELL	$6.42 - $9.0 $16,223 - $22,743	-2,527 Reduced 11.43%	19,573 $151,000
Q2 2019 Aug 14, 2019	BUY	$6.1 - $8.78 $3,050 - $4,390	500 Added 2.31%	22,100 $151,000
Q1 2019 May 13, 2019	BUY	$7.6 - $9.4 $37,240 - $46,060	4,900 Added 29.34%	21,600 $174,000
Q4 2018 Feb 11, 2019	BUY	$6.51 - $10.19 $108,717 - $170,173	16,700 New	16,700 $125,000

241K

Ticker AGLE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 61,172,500
Market Cap $1.69B
Description
Aeglea BioTherapeutics, Inc., a clinical-stage biotechnology company, designs and develops human enzyme therapeutics for the treatment of patients and families with rare metabolic diseases. The company's lead product candidate is pegzilarginase, a recombinant human Arginase 1 that is in Phase III PEACE trial to evaluate the safety and efficacy f...

Get notified when there are updates to the investment portfolio of State Of Wisconsin Investment Board, based on Form 13F filings with the SEC.

Stay updated on State Of Wisconsin Investment Board with notifications on news.